J.W. Cole Advisors’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.3M | Buy |
10,744
+395
| +4% | +$47.8K | 0.03% | 574 |
|
|
2025
Q1 | $1.15M | Buy |
10,349
+4,969
| +92% | +$554K | 0.04% | 489 |
|
|
2024
Q4 | $523K | Sell |
5,380
-930
| -15% | -$90.5K | 0.02% | 590 |
|
|
2024
Q3 | $726K | Buy |
6,310
+257
| +4% | +$29.6K | 0.03% | 475 |
|
|
2024
Q2 | $644K | Sell |
6,053
-261
| -4% | -$27.8K | 0.03% | 452 |
|
|
2024
Q1 | $611K | Buy |
6,314
+464
| +8% | +$44.9K | 0.03% | 471 |
|
|
2023
Q4 | $591K | Sell |
5,850
-814
| -12% | -$82.2K | 0.03% | 436 |
|
|
2023
Q3 | $679K | Buy |
6,664
+87
| +1% | +$8.86K | 0.05% | 338 |
|
|
2023
Q2 | $664K | Buy |
6,577
+121
| +2% | +$12.2K | 0.05% | 356 |
|
|
2023
Q1 | $594K | Sell |
6,456
-303
| -4% | -$27.9K | 0.04% | 407 |
|
|
2022
Q4 | $613K | Buy |
6,759
+355
| +6% | +$32.2K | 0.05% | 366 |
|
|
2022
Q3 | $487K | Buy |
6,404
+391
| +7% | +$29.7K | 0.04% | 402 |
|
|
2022
Q2 | $508K | Sell |
6,013
-62
| -1% | -$5.24K | 0.04% | 407 |
|
|
2022
Q1 | $533K | Sell |
6,075
-43
| -0.7% | -$3.77K | 0.04% | 436 |
|
|
2021
Q4 | $535K | Buy |
6,118
+27
| +0.4% | +$2.36K | 0.03% | 442 |
|
|
2021
Q3 | $498K | Buy |
6,091
+479
| +9% | +$39.2K | 0.04% | 261 |
|
|
2021
Q2 | $512K | Buy |
5,612
+2,114
| +60% | +$193K | 0.04% | 425 |
|
|
2021
Q1 | $299K | Sell |
3,498
-109
| -3% | -$9.32K | 0.03% | 518 |
|
|
2020
Q4 | $341K | Sell |
3,607
-3,635
| -50% | -$344K | 0.04% | 442 |
|
|
2020
Q3 | $630K | Buy |
+7,242
| New | +$630K | 0.05% | 357 |
|
|
2020
Q1 | – | Sell |
-3,765
| Closed | -$357K | – | 370 |
|
|
2019
Q4 | $357K | Buy |
+3,765
| New | +$357K | 0.05% | 377 |
|